| Comprehensive molecular characterization of muscle-invasive bladder cancer AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ... Cell 171 (3), 540-556. e25, 2017 | 2215 | 2017 |
| Integrative molecular characterization of malignant pleural mesothelioma J Hmeljak, F Sanchez-Vega, KA Hoadley, J Shih, C Stewart, D Heiman, ... Cancer discovery 8 (12), 1548-1565, 2018 | 488 | 2018 |
| Integrated molecular characterization of testicular germ cell tumors H Shen, J Shih, DP Hollern, L Wang, R Bowlby, SK Tickoo, V Thorsson, ... Cell reports 23 (11), 3392-3406, 2018 | 364 | 2018 |
| The integrated genomic landscape of thymic epithelial tumors M Radovich, CR Pickering, I Felau, G Ha, H Zhang, H Jo, KA Hoadley, ... Cancer cell 33 (2), 244-258. e10, 2018 | 309 | 2018 |
| Phase III, randomized, double-blind, multicenter trial comparing orteronel (TAK-700) plus prednisone with placebo plus prednisone in patients with metastatic castration … K Fizazi, R Jones, S Oudard, E Efstathiou, F Saad, R De Wit, J De Bono, ... Journal of Clinical Oncology 33 (7), 723, 2015 | 134 | 2015 |
| MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients CM da Silva Martinelli, A van Helvoort Lengert, FM Cárcano, ECA Silva, ... Oncotarget 8 (31), 50608, 2017 | 58 | 2017 |
| The Warburg effect is associated with tumor aggressiveness in testicular germ cell tumors M Bonatelli, ECA Silva, FM Cárcano, MG Zaia, LF Lopes, ... Frontiers in endocrinology 10, 417, 2019 | 34 | 2019 |
| What are the personal and professional characteristics that distinguish the researchers who publish in high-and low-impact journals? A multi-national web-based survey CE Paiva, RLC Araujo, BSR Paiva, C de Pádua Souza, FM Cárcano, ... ecancermedicalscience 11, 2017 | 33 | 2017 |
| Absence of microsatellite instability and BRAF (V600E) mutation in testicular germ cell tumors FM Cárcano, AH Lengert, DO Vidal, C Scapulatempo Neto, L Queiroz, ... Andrology 4 (5), 866-872, 2016 | 24 | 2016 |
| Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer F Pinto, N Pértega-Gomes, JR Vizcaíno, RP Andrade, FM Cárcano, ... Oncotarget 7 (20), 28891, 2016 | 24 | 2016 |
| Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib LE Zucca, MAM Matushita, RJ da Silva Oliveira, C Scapulatempo-Neto, ... Urologic Oncology: Seminars and Original Investigations 36 (1), 11. e13-11. e21, 2018 | 23 | 2018 |
| Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial AC Bragagnoli, RLC Araujo, MW Ferraz, LV Dos Santos, KC Abdalla, ... British Journal of Cancer 124 (6), 1072-1078, 2021 | 21 | 2021 |
| Primary monophasic synovial sarcoma of the kidney: a case report and review of literature H Lopes, CAD Pereira, LER Zucca, SV Serrano, SRM Silva, ... Clinical Medicine Insights: Oncology 7, CMO. S12243, 2013 | 19 | 2013 |
| Molecular biology of pediatric and adult male germ cell tumors MT Pinto, FM Carcano, AGS Vieira, ERM Cabral, LF Lopes Cancers 13 (10), 2349, 2021 | 15 | 2021 |
| Hotspot TERT promoter mutations are rare events in testicular germ cell tumors FM Cárcano, DO Vidal, A van Helvoort Lengert, CS Neto, L Queiroz, ... Tumor Biology 37, 4901-4907, 2016 | 15 | 2016 |
| Somatic copy number alterations and associated genes in clear-cell renal-cell carcinoma in Brazilian patients FG Fernandes, HCS Silveira, JNA Júnior, RA da Silveira, LE Zucca, ... International journal of molecular sciences 22 (5), 2265, 2021 | 14 | 2021 |
| Brachyury oncogene is a prognostic factor in high‐risk testicular germ cell tumors F Pinto, FM Cárcano, ECA da Silva, DO Vidal, C Scapulatempo‐Neto, ... Andrology 6 (4), 597-604, 2018 | 14 | 2018 |
| The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non … G Werutsky, FC Maluf, EH Cronemberger, V Carrera Souza, ... BMC cancer 19, 1-8, 2019 | 13 | 2019 |
| Eticidade do uso de placebo em pesquisa clínica: proposta de algoritmos decisórios JHTG Fregnani, AL Carvalho, FRL Paranhos, LS Viana, SV Serrano, ... Revista Bioética 23, 456-467, 2015 | 12 | 2015 |
| A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate … FC Maluf, FA Schutz, EH Cronemberger, MA Luz, SPS Martins, ... European Journal of Cancer 158, 63-71, 2021 | 11 | 2021 |
Luiz Fernando LopesDiretor Médico do Hospital de Câncer Infantojuvenil de BarretosVerified email at hcancerbarretos.com.br
